investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Epidemiological Study of Breast Cancer in Uganda and Cameroon
Dezheng Huo
2 Collaborator(s)
Funding source
AVON
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Epidemiological Study of Breast Cancer in Uganda and Cameroon
Related projects
Suzanne A Fuqua
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
Breast
Neil Johnson
Identifying BRCA1 protein variants that provide resistance to therapy
Breast
David H Haussler
Center for Big Data in Translational Genomics
Breast
Thomas Westbrook
Discovering Genetic Networks of Triple-Negative Breast Cancer
Breast
Javed Khan
Targeting FGFR4, RAS, and PAX3-FOXO1 Gene in Rhabdomyosarcoma
Breast
Pediatric oncology or childhood cancer
Naoto Ueno
Understanding EGFR's Role in TNBC by an Animal Model
Breast
Charlotte Kuperwasser
Analysis of the cellular and molecular determinants of the human breast hierarchy
Breast
Pathology
Stuart Keith Calderwood
Extracellular Hsp70 and hyperthermia in tumor therapy
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast